Search

Your search keyword '"Tarraga, Lluis"' showing total 198 results

Search Constraints

Start Over You searched for: Author "Tarraga, Lluis" Remove constraint Author: "Tarraga, Lluis"
198 results on '"Tarraga, Lluis"'

Search Results

1. Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic

2. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

3. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results

4. Clinical Value of Plasma pTau181 to Predict Alzheimer's Disease Pathology in a Large Real-World Cohort of a Memory Clinic

5. Identification of a sex-specific genetic signature in dementia with Lewy bodies: a meta-analysis of genome-wide association studies

7. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

8. New insights into the genetic etiology of Alzheimer's disease and related dementias

9. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

10. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type

11. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer’s type

12. Metabolic syndrome impact on cognitive composites domain scores and on white matter hyperintensities in subjective cognitive decline: The FACEHBI Cohort

13. Comparison of automated CLEIA and manual ELISA immunoassays for CSF AD biomarkers: The Fundació ACE Biomarker Research Program (FACEBREP)

14. Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP

15. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

16. Identification of undiagnosed dementia cases using a web-based pre-screening tool: The MOPEAD project

17. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

18. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019)

19. Quantitative thresholds for 18 F‐florbetaben PET for the detection of low amyloid load

20. Interaction of neuropsychiatric symptoms with APOE e4 and conversion to dementia in MCI patients in a memory clinic

21. Pre‐screening models for patient engagement: The MOPEAD project

22. How gender and sex influence clinical trial recruitment in Alzheimer's disease: Findings from Fundació ACE Barcelona Alzheimer Treatment and Research Center

23. Gender and sex bias in clinical trial recruitment in Alzheimer's disease: Findings from Fundació ACE

24. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes

26. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia

27. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE ¿4 Non-carriers

28. Exploratory analysis of seven Alzheimer's disease genes: disease progression

29. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A beta, tau, immunity and lipid processing

30. GBA and APOE epsilon 4 associate with sporadic dementia with Lewy bodies in European genome wide association study

31. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

32. APOE STATUS MODULATES BRAIN PATTERNS OF AMYLOID DISTRIBUTION IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE (SCD) FROM THE FACEHBI STUDY

34. Estrogen receptor alpha gene variants are associated with Alzheimer's disease

35. Safety, tolerability and immunogenicity of an active anti-Aß 40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial

37. Exploring Genetic Associations of Alzheimer's Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes

38. P1‐428: APOE STATUS MODULATES BRAIN PATTERNS OF AMYLOID DISTRIBUTION IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE (SCD) FROM THE FACEHBI STUDY

39. P1‐540: NON‐SCHEDULED CONSULTATIONS CAN HELP TO IDENTIFY HIGHLY DEMANDING DEMENTIA PATIENTS

40. P2‐139: GENOME‐WIDE ASSOCIATION STUDY OF ALZHEIMER'S DISEASE (AD) SUSCEPTIBILITY USING THE FUNDACIO ACE GENOME REPOSITORY: THE GR@ACE PROJECT

42. A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer's Disease, Dementia with Lewy-Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity

43. PLCG2 Protective Variant p.P522R Modulates Tau Pathology and Disease Progression in Patients with Mild Cognitive Impairment

44. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

45. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

46. [O1–13–06]: THE SPANISH VERSION OF FACE‐NAME ASSOCIATIVE MEMORY EXAM (S‐FNAME) PERFORMANCE IS RELATED TO AMYLOID BURDEN IN SUBJECTIVE COGNITIVE DECLINE

47. [P3-233]: CORRELATIONS BETWEEN PLASMA AND BRAIN BETA-AMYLOID LEVELS IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: THE FUNDACIÓ ACE HEALTHY BRAIN INITIATIVE (FACEHBI)

48. [P3-102]: GENETIC RISK FOR SCHIZOPHRENIA AND PSYCHOSIS IN ALZHEIMER DISEASE

49. [P1-141]: EXPLORING APOE GENOTYPE EFFECTS ON AD RISK AND BETA-AMYLOID BURDEN IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: THE FACEHBI STUDY RESULTS

50. [P1-554]: OPTIMAL HARMONIZATION OF COGNITIVE MEASURES ENHANCES THE DETECTION OF GENETIC EFFECTS ON ALZHEIMER's DISEASE PROGRESSION: A COMPARISON OF SIX STATISTICAL APPROACHES IN 1796 MCI PATIENTS FROM THREE COHORTS

Catalog

Books, media, physical & digital resources